SS-31 (Elamipretide): what it is, published preclinical and clinical research, limits of the evidence and UK regulatory status. Research use only.
William
Gonadorelin: what it is, published preclinical and clinical research, limits of the evidence and UK regulatory status. Research use only.
Glutathione: what it is, published preclinical and clinical research, limits of the evidence and UK regulatory status. Research use only.
hCG: what it is, published preclinical and clinical research, limits of the evidence and UK regulatory status. Research use only.
Epitalon: what it is, published preclinical and clinical research, limits of the evidence and UK regulatory status. Research use only.
AOD-9604: what it is, published preclinical and clinical research, limits of the evidence and UK regulatory status. Research use only.
MOTS-c: what it is, published preclinical and clinical research, limits of the evidence and UK regulatory status. Research use only.
CJC-1295 and Ipamorelin explained for UK research: how the GHRH-plus-ghrelin pairing works, dosing described in the literature, side-effect signals, purity checks and FAQs.
Full documentation of Peptides Lab UK’s quality standards: independent third-party HPLC, mass-spectrometry identity confirmation, endotoxin quantification, batch-specific COA, cold-chain shipping, and chain-of-custody protocols. 2026 UK research-grade SOP reference.
Survodutide: plain-English summary of published research, mechanism, evidence limits and laboratory handling. For laboratory research use only.
UK laboratory research reference on cagrilintide (long-acting amylin analogue) and CagriSema (cagrilintide + semaglutide combination): receptor pharmacology, REDEFINE-1 and REDEFINE-2 Phase 3 data, comparison with GLP-1 mono-agonists, protocol design. 2026 research-grade reference.
Melanotan-2 MT-II: plain-English summary of published research, mechanism, evidence limits and laboratory handling. For laboratory research use only.
